Nobivac Intra-Trac 3 Intranasal Vaccine for Dogs
Canine Adenovirus Type 2 - Parainfluenza - Bordetella Bronchiseptica Vaccine
Modified Live Virus and Avirulent Live Culture | Thimerosal-Free
The Nobivac Intra-Trac 3 intranasal vaccine is a proven veterinary solution for protecting dogs from key respiratory pathogens: canine adenovirus type 2, canine parainfluenza virus, and Bordetella bronchiseptica. This modified live virus and avirulent live culture vaccine is formulated for intranasal administration and offers fast, localized immunity starting as early as 48 hours post-vaccination.
Designed for dogs 3 weeks of age and older, this vaccine is safe for use in puppies due to the absence of interference from maternal antibodies. It is available in flexible dosing options (0.5 mL or 1 mL) and includes intranasal applicators for easy administration.
What It Protects Against:
-
Bordetella bronchiseptica: A primary cause of kennel or canine cough (infectious tracheobronchitis), this bacterium spreads easily in environments with close dog-to-dog contact. It causes persistent coughing and respiratory irritation.
-
Canine Parainfluenza Virus: A highly contagious respiratory virus that contributes to kennel cough and can lead to fever, coughing, nasal discharge, and lethargy, especially when combined with other pathogens.
-
Canine Adenovirus Type 2 (CAV-2): A viral agent linked to respiratory disease in dogs, including coughing and bronchitis. It is distinct from CAV-1, which causes infectious canine hepatitis, but can contribute to respiratory illness as part of the kennel cough.
Key Benefits:
- Provides triple protection against Bordetella bronchiseptica, canine parainfluenza virus, and canine adenovirus type 2.
- Effective for dogs as young as 3 weeks of age.
- Intranasal administration with included nasal applicator for non-invasive delivery.
- Onset of immunity begins in as little as 48 hours for Bordetella.
- Proven duration of immunity for Bordetella bronchiseptica: at least 1 year.
- Thimerosal-free formula for safer vaccination.
Dosage and Administration:
- Rehydrate the lyophilized vaccine with the sterile diluent provided.
- Draw the rehydrated solution into a syringe and attach the nasal applicator.
- Administer 0.5 mL or 1 mL intranasally into one or both nostrils.
- Use immediately after reconstitution. Do not inject.
For small dogs and puppies, a 0.5 mL dose may reduce discomfort. Rehydrate with an equal volume of sterile diluent based on the dose required.
Storage and Handling:
- Store between 2°C - 8°C (35°F - 46°F). Do not freeze.
- Use rehydrated vaccine immediately. Do not mix with other products unless specified.
- Dispose of unused vaccine and components properly.
Cautions and Warnings:
- For intranasal use only. Do not inject. Injection may cause serious systemic reactions.
- May cause mild canine cough syndrome post-vaccination.
- Contains penicillin, streptomycin, and nystatin as preservatives.
- Not tested in pregnant bitches. Avoid contact with human mucous membranes. In case of exposure, consult a physician.
Consult your veterinarian for guidance on revaccination intervals. Historically, annual boosters have been recommended; however, the need for revaccination has not been established for all components.
For animal use only. Not for human use. Do not repack or resell individual contents without a valid veterinarian-client-patient relationship.
View manufacturer and/or label information
A Valid veterinarian prescription is required to purchase this item in the state of Minnesota. Please contact your veterinarian for a prescription.
All vaccines are NON-RETURNABLE and NON-REFUNDABLE.
